Literature DB >> 9465897

Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.

L Heidet1, L Cohen-Solal, E Boye, P Thorner, M J Kemper, A David, L Larget Piet, J Zhou, F Flinter, X Zhang, M C Gubler, C Antignac.   

Abstract

Diffuse leiomyomatosis (DL) with Alport syndrome (AS) has been shown to be associated with contiguous gene deletions of the COL4A5 and COL4A6 genes, with the COL4A6 breakpoint of the deletions invariably located in the large intron 2 of the gene. We describe four YAC clones covering the locus and a refined restriction map of the entire COL4A6 gene. These resources have allowed us to make a precise estimate of the size of COL4A6 introns 2 and 3, as well as the size of the gene itself. We also describe five novel deletions which, in conjunction with previous reports, allow the definition of a 90-kb critical region in which to search for a gene or other entity involved in the pathogenesis of DL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9465897     DOI: 10.1159/000134666

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  9 in total

1.  Alport syndrome with diffuse leiomyomatosis. When and when not?

Authors:  J H Miner
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

3.  Absence of the alpha6(IV) chain of collagen type IV in Alport syndrome is related to a failure at the protein assembly level and does not result in diffuse leiomyomatosis.

Authors:  K Zheng; S Harvey; Y Sado; I Naito; Y Ninomiya; R Jacobs; P S Thorner
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Fusion of the COL4A5 Gene With NR2F2-AS1 in a Hemangioma Carrying a t(X;15)(q22;q26) Chromosomal Translocation.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Ingvild Lobmaier; Kristin Andersen; Marius Lund-Iversen; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

5.  Alport syndrome and leiomyomatosis: the first deletion extending beyond COL4A6 intron 2.

Authors:  Vera Uliana; Elena Marcocci; Mafalda Mucciolo; Ilaria Meloni; Claudia Izzi; Carlo Manno; Mirella Bruttini; Francesca Mari; Francesco Scolari; Alessandra Renieri; Leonardo Salviati
Journal:  Pediatr Nephrol       Date:  2010-12-14       Impact factor: 3.714

Review 6.  Familial hematurias: what we know and what we don't.

Authors:  Clifford E Kashtan
Journal:  Pediatr Nephrol       Date:  2005-04-27       Impact factor: 3.714

7.  A human-mouse chimera of the alpha3alpha4alpha5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- Alport mice.

Authors:  Laurence Heidet; Dorin-Bogdan Borza; Mélanie Jouin; Mireille Sich; Marie-Geneviève Mattei; Yoshikazu Sado; Billy G Hudson; Nicholas Hastie; Corinne Antignac; Marie-Claire Gubler
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis.

Authors:  Y Segal; B Peissel; A Renieri; M de Marchi; A Ballabio; Y Pei; J Zhou
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 9.  Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.

Authors:  Akulapalli Sudhakar; Chandra S Boosani
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.